Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Giraud

Showing results (21-30 of 212) with videos related to

Pageof 22
Sort By:
Oncoscience|December 19, 2015
RUNX3 methylation and anti-tumor immunityTrevelyan R Menheniott, Louise M Judd, Andrew S Giraud
The American Journal of Physiology|June 1, 1997
Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulcerationG A Cook, N D Yeomans, A S Giraud
Cellular Microbiology|September 3, 2015
STAT3: a critical component in the response to Helicobacter pylori infectionTrevelyan R Menheniott, Louise M Judd, Andrew S Giraud
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|January 7, 2011
The extracellular matrix in digestive cancerDaniel L Worthley, Andrew S Giraud, Timothy C Wang
Journal of Gastroenterology and Hepatology|November 1, 1992
Adaptation of rat gastric mucosa to repeated doses of non-salicylate non-steroidal anti-inflammatory drugsM V Skeljo, A S Giraud, N D Yeomans
Gastroenterology|July 3, 1998
Selective COX-2 inhibitors: are they safe for the stomach?N D Yeomans, G A Cook, A S Giraud
Digestion|January 1, 1992
The role of acid regulation in the treatment of NSAID-induced mucosal damageN D Yeomans, M V Skeljo, A S Giraud
Journal of Gastroenterology and Hepatology|January 1, 1994
Gastric mucosal defensive factors: the therapeutic strategyN D Yeomans, M V Skeljo, A S Giraud
Current Gastroenterology Reports|February 15, 2001
Adaptation of the stomach to injury from nonsteroidal anti-inflammatory drugsB M Alderman, A S Giraud, N D Yeomans
Molecular and Cellular Endocrinology|October 1, 1987
Distribution and molecular forms of immunoreactive bombesin in the ovine median eminenceA S Giraud, A I Smith, S E Rundle
Pageof 22

Showing results (21-30 of 212) with videos related to

Sort By:
Pageof 22
Oncoscience|December 19, 2015
RUNX3 methylation and anti-tumor immunityTrevelyan R Menheniott, Louise M Judd, Andrew S Giraud
The American Journal of Physiology|June 1, 1997
Temporal expression of trefoil peptides in the TGF-alpha knockout mouse after gastric ulcerationG A Cook, N D Yeomans, A S Giraud
Cellular Microbiology|September 3, 2015
STAT3: a critical component in the response to Helicobacter pylori infectionTrevelyan R Menheniott, Louise M Judd, Andrew S Giraud
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|January 7, 2011
The extracellular matrix in digestive cancerDaniel L Worthley, Andrew S Giraud, Timothy C Wang
Journal of Gastroenterology and Hepatology|November 1, 1992
Adaptation of rat gastric mucosa to repeated doses of non-salicylate non-steroidal anti-inflammatory drugsM V Skeljo, A S Giraud, N D Yeomans
Gastroenterology|July 3, 1998
Selective COX-2 inhibitors: are they safe for the stomach?N D Yeomans, G A Cook, A S Giraud
Digestion|January 1, 1992
The role of acid regulation in the treatment of NSAID-induced mucosal damageN D Yeomans, M V Skeljo, A S Giraud
Journal of Gastroenterology and Hepatology|January 1, 1994
Gastric mucosal defensive factors: the therapeutic strategyN D Yeomans, M V Skeljo, A S Giraud
Current Gastroenterology Reports|February 15, 2001
Adaptation of the stomach to injury from nonsteroidal anti-inflammatory drugsB M Alderman, A S Giraud, N D Yeomans
Molecular and Cellular Endocrinology|October 1, 1987
Distribution and molecular forms of immunoreactive bombesin in the ovine median eminenceA S Giraud, A I Smith, S E Rundle
Pageof 22